$3.66
▼ -9.0% Today
as of Oct 23, 11:18 ET
Last 30 days
Recent Press Releases & News
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
Impact BioMedical to Effect 1-for-12.62 Reverse Stock Split
IBO earnings at a glance
Impact BioMedical, Inc. (IBO) is scheduled to report earnings on Friday, November 6, 2026 — in 14 days. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.5% on average; after the most recent report on May 12, 2026 it moved +0.0%. The share price of $3.66 sits near its 52-week low.
Overview
52-week range
$2.43
$11
15% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.5%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.01 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.02 | — | — | +81.8% | 0.0% | earnings |
| Fri Nov 7, 2025 | Sep/2025 | $-0.12 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-1.18 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.11 | — | — | — | -5.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.06 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.09 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.10 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.02 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.01 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Nov 6, 2026 | Sep/2026 | OTHER | — | -$1.52 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3,000 | $7,000 | — | $18,000 | $7,000 | — | — | — |
| Cost of revenue | $1,000 | — | — | $1,000 | $1,000 | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-702,000 | $-2M | — | $-948,000 | $-1M | $-1M | — | $-1M |
| Net income | $-699,000 | $-2M | — | $-1M | $-14M | $-1M | — | $4M |
| EPS (diluted) | $-0.01 | $-0.02 | — | $-0.12 | $-1.18 | $-0.11 | — | $0.06 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10,000 | $20,000 | $3,000 | $12,000 | $624,000 | $1M | $2M | $3M |
| Inventory | $62,000 | $63,000 | $63,000 | $485,000 | $486,000 | $489,000 | — | — |
| Total current assets | $320,000 | $377,000 | $411,000 | $917,000 | $1M | $2M | $2M | $3M |
| Total assets | $17M | $17M | $17M | $18M | $19M | $20M | $20M | $47M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $2M | $2M | $27M | $26M | $13M | $13M | $12M |
| Total equity | $11M | $11M | $12M | $-12M | $-7M | $7M | $4M | $34M |
Implied volatility — last 90 days
No IV snapshots yet for IBO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
IBO earnings FAQ
When is IBO's next earnings date?
Impact BioMedical, Inc. is expected to report on November 6, 2026.
How does IBO stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.5%, up 0 times and down 2 times.